… New potential drugs based on vanadium are being developed as possible treatments for …
In this regard, our working group developed metforminium decavanadate (MetfDeca), a …

… Above this temperature, an exothermic mass loss takes place that corresponds to the
combustion of the metforminium cations per decavanadate unit [%mass, calc. (found) for 6 × C 4 H …

… New potential drugs based on vanadium are being developed as possible treatments for …
In this regard, our working group developed metforminium decavanadate (MetfDeca), a …

… Aimed as a novel potential metallopharmaceutical [40,41], in vivo studies have described a
… A compound containing the metforminium cation and the decavanadate anion (Metf-V 10 ) …

… decavanadate ([V 10 O … potential application of ZnO-MWCNT as a novel and effective
therapeutic approach for combating Toxoplasma gondii, opening up new possibilities for treating …

… metformin is the first-line drug in the therapy of diabetes mellitus type 2, these two agents
could potentially be combined in a new metallopharmaceutical compound for the prevention of …

… Therefore, in that study of vanadium complexes their beneficial physiological function, their
potential toxicity and side effect were considered. Searching literature revealed no published …

… potential of vanadium complexes with non-cancer drugs, known as “hard repurposing”, for
cancer treatment… (B) Ball and stick representation of metforminium decavanadate (H 2 Metf) 3 […

… The results showed that MetfDeca treatment diminished proinflammatory cytokines in the
hippocampus of rats with MS; hence it is possible to think that it exerts similar effects to other …

… such as decavanadate and metforminium-decavanadate with preventive and corrective …
metallopharmaceuticals in managing diabetes, such as a potential therapeutic target in treating …